Prevalence of chronic kidney disease (CKD) is increasing and CKD has a long asymptomatic phase suitable for screening. SCORED (Screening for Occult Renal Disease) is a prescreening test which has compared favorably with KEEP. We report the results of SCORED testing in subjects attending a World Kidney Day event. After SCORED, subjects were tested for creatinine, urinary albumin and creatinine, and renal ultrasound. Eighty-eight subjects participated (32 men; mean age 59.7 ± 14.8 years; 58% hypertensive and 15.9% diabetics) of which 60 had a high score for kidney disease. Thirty-eight of 47 (80.8%) subjects that were further evaluated had a high-risk score. All subjects with CKD had a high score (100% sensitivity). SCORED showed low specificity (24.3%), but a high negative predictive value (100%). Including albuminuria in the definition of CKD increased the positive predictive value to 43.6%. In conclusion, SCORED is good for prescreening subjects for CKD in a European population as it captures all patients with CKD. Moreover, in subjects with low risk, the probability of CKD is low. SCORED is useful in alerting the general population and the medical community about the risk factors of CKD.

Keywords:
Chronic kidney disease, Prescreening, SCORED
1.
Levey AS, Coresh J: Chronic kidney disease. Lancet 2012;379:165–180.
2.
Coresh J, Stevens LA, Levey AS: Chronic kidney disease is common: what do we do next? Nephrol Dial Transpl 2008;23:1122–1125.
3.
ERA-EDTA registry report 2009. www.era-edta-reg.org/.
4.
Vinhas J, Gardete-Correia L, Boavida JM, Raposo JF, Raposo AM, Fona MC, et al: Prevalence of chronic kidney disease and associated risk factors, and risk of end-stage renal disease: data from PREVADIAB study. Nephron Clin Pract 2011;119:c35–c40.
5.
Bang H, Vupputuri S, Shoham DA, Klemmer PJ, Falk RJ, Mazumdar M, et al: Screening for Occult Renal Disease (SCORED): a simple prediction model for chronic kidney disease. Arch Intern Med 2007;167:374–381.
6.
Bang H, Mazumdar M, Newman G, Bomback AS, Ballantyne CM, Jaffe AS, et al: Screening for kidney disease in vascular patients: Screening for Occult Renal Disease Experience (SCORED). Nephrol Dial Transpl 2009;24:2452–2457.
7.
Kwon KS, Bang H, Bomback AS, Koh DH, Yum JH, Lee JH, et al: A simple prediction score for kidney disease in the Korean population. Nephrology 2012;17:278–284.
8.
Stevens LA, Schmid CA, Zhang YL, et al: Development and validation of GFR-estimating equations using diabetes, transplant and weight. Nephrol Dial Transpl 2010;25:449–457.
9.
Levey AS, Stevens LA, Schmid CH, et al: A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604–612.
10.
Levey AS, de Jong PE, Matsushita K, et al: The definition, classification and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011;80:17–28.
11.
Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004;164:659–663.
12.
Bang H, Mazumdar M, Kern LM, Shoham DA, August PA, Kshirsargar AV: Validation and comparison of a novel screening guideline for kidney disease: KEEPing SCORED. Arch Intern Med 2008;168; 432–436.
13.
Lucas SM, Nuss G, Stern J, et al: The Screening for Occult Renal Disease (SCORED) values is associated with a higher risk of having or developing chronic kidney disease in patients treated for small, unilateral renal masses. Cancer 2008;113:2681–2686.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.